Whittier Trust’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $247K | Hold |
1,158
| – | – | ﹤0.01% | 595 |
|
|
2026
Q1 | $230K | Hold |
1,158
| – | – | ﹤0.01% | 559 |
|
|
2025
Q4 | $209K | Sell |
1,158
-106
| -8% | -$19.3K | ﹤0.01% | 589 |
|
|
2025
Q3 | $227K | Sell |
1,264
-294
| -19% | -$52.2K | ﹤0.01% | 567 |
|
|
2025
Q2 | $280K | Hold |
1,558
| – | – | ﹤0.01% | 593 |
|
|
2025
Q1 | $264K | Hold |
1,558
| – | – | ﹤0.01% | 600 |
|
|
2024
Q4 | $235K | Buy |
1,558
+400
| +35% | +$62.2K | ﹤0.01% | 630 |
|
|
2024
Q3 | $180K | Hold |
1,158
| – | – | ﹤0.01% | 689 |
|
|
2024
Q2 | $159K | Hold |
1,158
| – | – | ﹤0.01% | 687 |
|
|
2024
Q1 | $154K | Hold |
1,158
| – | – | ﹤0.01% | 705 |
|
|
2023
Q4 | $160K | Sell |
1,158
-1,793
| -61% | -$236K | ﹤0.01% | 677 |
|
|
2023
Q3 | $360K | Buy |
2,951
+19
| +0.6% | +$2.53K | 0.01% | 528 |
|
|
2023
Q2 | $412K | Hold |
2,932
| – | – | 0.01% | 494 |
|
|
2023
Q1 | $415K | Hold |
2,932
| – | – | 0.01% | 495 |
|
|
2022
Q4 | $459K | Sell |
2,932
-7
| -0.2% | -$1.01K | 0.01% | 483 |
|
|
2022
Q3 | $361K | Hold |
2,939
| – | – | 0.01% | 510 |
|
|
2022
Q2 | $391K | Hold |
2,939
| – | – | 0.01% | 504 |
|
|
2022
Q1 | $402K | Buy |
2,939
+7
| +0.2% | +$976 | 0.01% | 529 |
|
|
2021
Q4 | $507K | Hold |
2,932
| – | – | 0.01% | 476 |
|
|
2021
Q3 | $426K | Hold |
2,932
| – | – | 0.01% | 488 |
|
|
2021
Q2 | $387K | Hold |
2,932
| – | – | 0.01% | 519 |
|
|
2021
Q1 | $376K | Sell |
2,932
-1
| -0% | -$123 | 0.01% | 516 |
|
|
2020
Q4 | $350K | Buy |
2,933
+1
| +0% | +$122 | 0.01% | 490 |
|
|
2020
Q3 | $336K | Sell |
2,932
-17
| -0.6% | -$2.01K | 0.01% | 481 |
|
|
2020
Q2 | $336K | Sell |
2,949
-100
| -3% | -$10.6K | 0.01% | 457 |
|
|
2020
Q1 | $244K | Buy |
3,049
+117
| +4% | +$12.1K | 0.01% | 478 |
|
|
2019
Q4 | $313K | Hold |
2,932
| – | – | 0.01% | 468 |
|
|
2019
Q3 | $314K | Hold |
2,932
| – | – | 0.01% | 473 |
|
|
2019
Q2 | $299K | Hold |
2,932
| – | – | 0.01% | 467 |
|
|
2019
Q1 | $264K | Hold |
2,932
| – | – | 0.01% | 481 |
|
|
2018
Q4 | $244K | Buy |
2,932
+1,774
| +153% | +$166K | 0.01% | 473 |
|
|
2018
Q3 | $125K | Sell |
1,158
-39
| -3% | -$4.28K | ﹤0.01% | 595 |
|
|
2018
Q2 | $132K | Hold |
1,197
| – | – | ﹤0.01% | 574 |
|
|
2018
Q1 | $120K | Buy |
1,197
+39
| +3% | +$3.99K | ﹤0.01% | 607 |
|
|
2017
Q4 | $114K | Buy |
1,158
+130
| +13% | +$12.3K | ﹤0.01% | 599 |
|
|
2017
Q3 | $96K | Hold |
1,028
| – | – | ﹤0.01% | 617 |
|
|
2017
Q2 | $114K | Hold |
1,028
| – | – | ﹤0.01% | 553 |
|
|
2017
Q1 | $101K | Hold |
1,028
| – | – | ﹤0.01% | 582 |
|
|
2016
Q4 | $94K | Hold |
1,028
| – | – | ﹤0.01% | 598 |
|
|
2016
Q3 | $87K | Hold |
1,028
| – | – | ﹤0.01% | 602 |
|
|
2016
Q2 | $84K | Hold |
1,028
| – | – | ﹤0.01% | 625 |
|
|
2016
Q1 | $73K | Hold |
1,028
| – | – | ﹤0.01% | 646 |
|
|
2015
Q4 | $73K | Hold |
1,028
| – | – | ﹤0.01% | 652 |
|
|
2015
Q3 | $63K | Hold |
1,028
| – | – | ﹤0.01% | 669 |
|
|
2015
Q2 | $75K | Sell |
1,028
-179
| -15% | -$13.2K | ﹤0.01% | 659 |
|
|
2015
Q1 | $93K | Buy |
1,207
+179
| +17% | +$12.8K | ﹤0.01% | 605 |
|
|
2014
Q4 | $69K | Hold |
1,028
| – | – | ﹤0.01% | 614 |
|
|
2014
Q3 | $62K | Hold |
1,028
| – | – | ﹤0.01% | 626 |
|
|
2014
Q2 | $60K | Hold |
1,028
| – | – | ﹤0.01% | 630 |
|
|
2014
Q1 | $60K | Hold |
1,028
| – | – | ﹤0.01% | 631 |
|
|
2013
Q4 | $55K | Hold |
1,028
| – | – | ﹤0.01% | 650 |
|
|
2013
Q3 | $64K | Hold |
1,028
| – | – | ﹤0.01% | 617 |
|
|
2013
Q2 | $62K | Buy |
+1,028
| New | +$61.2K | ﹤0.01% | 616 |
|
Other funds holding DGX
EIG
Whittier Trust's DGX Position: Q2 2026 in Review
Whittier Trust held its Quest Diagnostics (DGX) position steady in Q2 2026 at 1,158 shares worth $247K. The position accounts for ﹤0.01% of the portfolio, ranked #595.
Whittier Trust first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. The position peaked at $507K in Q4 2021. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Whittier Trust held 1,158 shares of Quest Diagnostics worth $247K as of Q2 2026.
- Whittier Trust left its Quest Diagnostics share count unchanged in Q2 2026.
- Quest Diagnostics made up ﹤0.01% of Whittier Trust's portfolio in Q2 2026, its #595 holding.
- Whittier Trust first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
- Whittier Trust's Quest Diagnostics position peaked at $507K in Q4 2021.
- 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Whittier Trust's 13F filing for Q2 2026, filed 28 Jul 2026.